Jan Aushadhi Encyclopedia Part 3: Quality Assurance & NABL Testing

The biggest hurdle in the adoption of generic medicines is the psychological fear that “low price = low quality.” To combat this, the PMBI has established a quality assurance framework that is more rigorous than many private pharmaceutical chains.

---

1. Sourcing Only from the Best: WHO-GMP Standards

The first line of defense is the selection of manufacturers. PMBI does not buy from just any factory.

• Rule: Medicines are procured exclusively from WHO-GMP (World Health Organization - Good Manufacturing Practices) certified manufacturers.
• What this means: These manufacturers are globally recognized for maintaining sterile environments, accurate dosing, and high-tech machinery. They are the same factories that often manufacture branded drugs for export to Europe and the USA.

2. The Mandatory 2-Stage Testing Protocol

Unlike some private stockists who might perform random checks, PMBI follows a “100% Batch Testing” rule.

Stage 1: Manufacturer Level

Before shipping the medicine to a PMBI warehouse, the manufacturer must conduct their own internal tests and provide a Certificate of Analysis (CoA) for that specific batch.

Stage 2: Independent NABL Validation

This is where the Jan Aushadhi scheme sets itself apart.

• Quarantine: Upon arrival at a PMBI warehouse, the entire batch is kept in a “Quarantine” zone. It cannot be sold or moved.
• Independent Sampling: Random samples from every single batch are picked by PMBI officials and sent to independent labs accredited by the NABL (National Accreditation Board for Testing and Calibration Laboratories).
• The Wait: The batch remains in quarantine for 7-10 days until the NABL lab provides a “Pass” report. If a batch fails even a single parameter, the entire shipment is rejected and the manufacturer is blacklisted.

---

3. Post-Market Surveillance: Random Shelf Checks

The quality control doesn’t end at the warehouse.

• Mystery Shopping: PMBI’s quality team frequently acts as regular customers to pick samples directly from the shelves of Jan Aushadhi Kendras.
• Stability Testing: These shelf-picked samples are sent back for testing to ensure the medicine remains potent throughout its entire shelf-life, even after transportation to remote areas.

4. Enhanced Oversight (2026 Update)

In a major move in 2026, PMBI signed an MoU with the Indian Pharmacopoeia Commission (IPC).

• Third-Party Audit: IPC now conducts additional, independent audits of the medicine quality at Jan Aushadhi outlets.
• Pharmacovigilance: Every Jan Aushadhi Kendra is now required to display a QR code for the Pharmacovigilance Programme of India (PvPI). Patients can scan this to report any adverse reaction or side effect directly to the government.

Summary

When you take a Jan Aushadhi pill, it has been tested at least twice—once by the maker and once by an independent government-authorized laboratory. By the time it reaches your hands, its efficacy and safety are scientifically verified.

In Part 4, we look at the Supply Chain: how these medicines reach the most remote villages in India.

---

Next: Part 4 - Supply Chain Mastery: From Factory to Kendra